Most Recent Articles about NVO
Biotech Stock Roundup: GILD Collaborates on NASH, FCSC Surges on Deal http://www.zacks.com/stock/news/382518/biotech-stock-roundup-gild-collaborates-on-nash-fcsc-surges-on-deal?cid=CS-ZC-FT-382518 Apr 17, 2019 - Key highlights of the past week are collaborations and pipeline updates.
Gilead to Collaborate with Novo Nordisk for NASH Treatment http://www.zacks.com/stock/news/381020/gilead-to-collaborate-with-novo-nordisk-for-nash-treatment?cid=CS-ZC-FT-381020 Apr 15, 2019 - Gilead Sciences (GILD) will collaborate with Novo Nordisk to develop treatments for liver disease, NASH.
Sangamo Rises on Positive Phase I/II Hemophilia Study Data http://www.zacks.com/stock/news/370133/sangamo-rises-on-positive-phase-i-ii-hemophilia-study-data?cid=CS-ZC-FT-370133 Apr 03, 2019 - Sangamo (SGMO) and partner Pfizer announce encouraging data from a phase I/II study evaluating their gene therapy candidate for treating hemophilia A.

Related Companies

Name Exchange Price Mkt Cap
LLY Eli Lilly and Company NYSE $105.71 $113.53B
ABT Abbott Laboratories NYSE $67.67 $118.71B
SNY Sanofi NYSE $43.75 $109.14B
BMY Bristol-Myers Squibb Company NYSE $61.3 $100.03B
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
Sector: Health Care > Industry: Major Pharmaceuticals